Company: CRLBF
Filing Date: 2025-03-14
Form Type: 40-F
Source: 0001832928-25-000006
Chunk: 10

Company: Cresco Labs Inc.
Filing Date: 2025-03-14
Form: 40-F
Chunk 10
---
PECTIONS
Not applicable.

### RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION
Not applicable.

### UNDERTAKING AND CONSENT TO SERVICE OF PROCESS

#### Undertaking
The Company undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to: the securities registered pursuant to Form 40-F; the securities in relation to which the obligation to file an annual report on Form 40-F arises; or transactions in said securities.

#### Consent to Service of Process
The Company has previously filed with the SEC a written consent to service of process on Form F-X. Any change to the name or address of the Company’s agent for service shall be communicated promptly to the SEC by amendment to the Form F-X referencing the file number of the Company.

### EXHIBIT INDEX
| Exhibit 
 Number  |     | Exhibit Description                                                                                                                                                                                                        |
| 99.1    |     | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Exchange Act, as adopted pursuant to Section 302 of theSarbanes-Oxley Act of 2002                                                               |
| 99.2    |     | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Exchange Act, as adopted pursuant to Section 302 of theSarbanes-Oxley Act of 2002                                                               |
| 99.3    |     | Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C.Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002        |
| 99.4    |     | Annual Information Form of the Company for the year ended December 31, 2024                                                                                                                                                |
| 99.5    |     | Management’s Discussion and Analysis of Financial Condition and Results of Operations for the years ended December 31, 2024 and 2023                                                                                       |
| 99.6    |     | Audited consolidated financial statements of the Company and notes thereto as at and for the years ended December 31, 2024 and 2023, together with the report of the Independent Registered Public Accounting Firm thereon |
| 99.7    |     | Consent of Marcum, LLP